birdflustocks.com
Home
Facts
Idea
Stocks
Brokers
July 13, 2023
birdflustocks.com
»
2023 July 13
July 13, 2023
BioCryst Pharmaceuticals: BofA upgraded BioCryst (BCRX) to Buy from Neutral with a $10 price target
By
admin
|
13
Jul, 23
|
BofA upgraded BioCryst (BCRX) to Buy from Neutral with a
Cidara Therapeutics: CD388 phase 2 study data coming soon?
By
admin
|
13
Jul, 23
|
Official Title: A Proof-of-concept, Randomized, Double-blind, Placebo-controlled, Phase 2a Study
Vir Biotechnology: VIR-2482 phase 2 study data coming soon?
By
admin
|
13
Jul, 23
|
Official Title: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Study to